1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Dr. Itay GoorAryeh: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation Alendronate 70mg weekly - Cervix Cancer | Phase 1 / Phase 2 | Not yet recruiting | Dr. Itay GoorAryeh | 65 | 2025-12-01 | 2025-11-24 |
Uterine Cervical Neoplasms (1)
Alendronate (1)